Kennedy Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ecovyst
ECVT
|
+$15.5M |
| 2 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$15.1M |
| 3 |
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
|
+$14.3M |
| 4 |
Boot Barn
BOOT
|
+$10.9M |
| 5 |
Cathay General Bancorp
CATY
|
+$10.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAC
Exactech Inc
EXAC
|
+$17.9M |
| 2 |
SKX
Skechers
SKX
|
+$17.3M |
| 3 |
Nektar Therapeutics
NKTR
|
+$16.1M |
| 4 |
Icon
ICLR
|
+$15.5M |
| 5 |
CCC
Calgon Carbon Corp
CCC
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.92% |
| 2 | Industrials | 16.76% |
| 3 | Technology | 12.98% |
| 4 | Consumer Discretionary | 11.4% |
| 5 | Healthcare | 8.88% |
Similar funds
Kennedy Capital Management's Q1 2018 Portfolio in Review
As of Q1 2018, Kennedy Capital Management held 813 positions worth $5.14B, down 8% from $5.58B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Kennedy Capital Management withdrew a net $302M in Q1 2018, closing 83 positions and reducing 467 holdings. Its most notable exit was Exactech Inc, an estimated $17.9M position sold in full.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Industrials and Technology.
Against the trend, Kennedy Capital Management opened a new position in DIPLOMAT PHARMACY, INC. worth $12.3M.
- Kennedy Capital Management's largest Q1 2018 buy was DIPLOMAT PHARMACY, INC.: 611,088 shares worth $12.3M.
- Kennedy Capital Management added most to Ecovyst in Q1 2018, an estimated $15.5M increase.
- Kennedy Capital Management's biggest Q1 2018 reduction was Skechers, cutting an estimated $17.3M.
- Kennedy Capital Management fully exited Exactech Inc in Q1 2018, selling an estimated $17.9M.
- Kennedy Capital Management's ten largest holdings make up 6.3% of its $5.14B portfolio in Q1 2018.
- Kennedy Capital Management opened 73 new positions and closed 83 in Q1 2018.
- Kennedy Capital Management's portfolio value fell 8% quarter-over-quarter to $5.14B.
Based on Kennedy Capital Management's 13F filing for Q1 2018, filed 14 May 2018.